Private company
BROADWOOD PARTNERS, L.P.
Hedge fund that raised $111.3 million in 1989 (SEC Form D). Summary from the record
Last updated Oct 21, 2026.
Overview
Corporate structure
BROADWOOD PARTNERS, L.P. sits at the top of its group. 5 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
- BROADWOOD PARTNERS, L.P. DE
- Insight Molecular Diagnostics Inc. Stake · Sacramento, California, United States
- Lineage Cell Therapeutics Stake · Carlsbad
- Serina Therapeutics, Inc. Stake · Huntsville, Alabama
- STAAR SURGICAL CO Stake · Monrovia, California, United States
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (4 companies). Each entity in the chart links to its source.
Leadership
Named in SEC Form D filings
People the company listed in its private-offering notices.
- General Partner and Investment Manager-- Broadwood Capital, Inc. named Aug 4, 20262
Filings
29 filings to the SEC since October 2021: 6 private raises, 23 other. The latest 20:
- Aug 31, 2026N-PX EDGAR
- Aug 14, 202613F-NT EDGAR
- Aug 4, 2026D/A EDGAR
- May 15, 202613F-NT EDGAR
- Feb 17, 202613F-NT EDGAR
- Nov 14, 202513F-NT EDGAR
- Aug 29, 2025N-PX EDGAR
- Aug 14, 202513F-NT EDGAR
- Aug 5, 2025D/A EDGAR
- May 15, 202513F-NT EDGAR
- Feb 14, 202513F-NT EDGAR
- Nov 14, 202413F-NT EDGAR
- Aug 30, 2024N-PX EDGAR
- Aug 14, 202413F-NT EDGAR
- Aug 6, 2024D/A EDGAR
- May 15, 202413F-NT EDGAR
- Feb 14, 202413F-NT EDGAR
- Dec 7, 2023D/A EDGAR
- Nov 14, 202313F-NT EDGAR
- Aug 14, 202313F-NT EDGAR
The 29 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Stakes it holds
BROADWOOD PARTNERS, L.P. has told the SEC it owns more than 5% of 4 companies, latest first (Schedules 13D and 13G).
- Insight Molecular Diagnostics Inc.SCHEDULE 13D/A Apr 15, 2022 to Apr 27, 20263
- STAAR SURGICAL COSCHEDULE 13D/A Oct 1, 2021 to Mar 13, 20264
- Lineage Cell TherapeuticsSCHEDULE 13D/A Mar 25, 2022 to Nov 14, 20255
- Serina Therapeutics, Inc.SC 13G/A Nov 14, 20246
Funding
Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.
- Private raises (Form D) $111.3M
Figures by year
| Year | Private raises (Form D) | Total |
|---|---|---|
| 1989 | $111.3M | $111.3M |
Private raises
Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6